Ann Lab Med.  2012 Jan;32(1):57-65. 10.3343/alm.2012.32.1.57.

Use of PCR with Sequence-specific Primers for High-Resolution Human Leukocyte Antigen Typing of Patients with Narcolepsy

Affiliations
  • 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. eskang@skku.edu
  • 2Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. seungbong.hong@samsung.com
  • 3Hallym Institution for Genome Application, Hallym University Sacred Heart Hospital, Hallym University, Anyang, Korea.

Abstract

BACKGROUND
Narcolepsy is a neurologic disorder characterized by excessive daytime sleepiness, symptoms of abnormal rapid eye movement (REM) sleep, and a strong association with HLA-DRB1*1501, -DQA1*0102, and -DQB1*0602. Here, we investigated the clinico-physical characteristics of Korean patients with narcolepsy, their HLA types, and the clinical utility of high-resolution PCR with sequence-specific primers (PCR-SSP) as a simple typing method for identifying DRB1*15/16, DQA1, and DQB1 alleles.
METHODS
The study population consisted of 67 consecutively enrolled patients having unexplained daytime sleepiness and diagnosed narcolepsy based on clinical and neurological findings. Clinical data and the results of the multiple sleep latency test and polysomnography were reviewed, and HLA typing was performed using both high-resolution PCR-SSP and sequence-based typing (SBT).
RESULTS
The 44 narcolepsy patients with cataplexy displayed significantly higher frequencies of DRB1*1501 (Pc= 0.003), DQA1*0102 (Pc=0.001), and DQB1*0602 (Pc=0.014) than the patients without cataplexy. Among patients carrying DRB1*1501-DQB1*0602 or DQA1*0102, the frequencies of a mean REM sleep latency of less than 20 min in nocturnal polysomnography and clinical findings, including sleep paralysis and hypnagogic hallucination were significantly higher. SBT and PCR-SSP showed 100% concordance for high-resolution typing of DRB1*15/16 alleles and DQA1 and DQB1 loci.
CONCLUSIONS
The clinical characteristics and somnographic findings of narcolepsy patients were associated with specific HLA alleles, including DRB1*1501, DQA1*0102, and DQB1*0602. Application of high-resolution PCR-SSP, a reliable and simple method, for both allele- and locus-specific HLA typing of DRB1*15/16, DQA1, and DQB1 would be useful for characterizing clinical status among subjects with narcolepsy.

Keyword

HLA; Genotype; Narcolepsy; Cataplexy

MeSH Terms

Adolescent
Adult
Aged
Alleles
Cataplexy/genetics
*DNA Probes, HLA
Female
Gene Frequency
Genetic Predisposition to Disease
Genotype
HLA-DQ Antigens/genetics
HLA-DRB1 Chains/genetics
*Histocompatibility Testing
Humans
Male
Middle Aged
Narcolepsy/*diagnosis/genetics
Phenotype
Polymerase Chain Reaction

Reference

1. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet. 2001. 68:686–699.
Article
2. Matsuki K, Honda Y, Juji T. Diagnostic criteria for narcolepsy and HLA-DR2 frequencies. Tissue Antigens. 1987. 30:155–160.
Article
3. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens. 1984. 24:316–319.
4. Mignot E, Lin X, Arrigoni J, Macaubas C, Olive F, Hallmayer J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep. 1994. 17:8 Suppl. S60–S67.
5. Mignot E, Kimura A, Lattermann A, Lin X, Yasunaga S, Mueller-Eckhardt G, et al. Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy. Tissue Antigens. 1997. 49:329–341.
6. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997. 20:1012–1020.
7. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15(DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology. 1997. 48:1550–1556.
8. Hong SC, Lin L, Lo B, Jeong JH, Shin YK, Kim SY, et al. DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol. 2007. 68:59–68.
9. Roh EY, Park MH, Park H, Park DH, Choi JB, Kim SJ, et al. Association of HLA-DR and -DQ genes with narcolepsy in Koreans: comparison with two control groups, randomly selected subjects and DRB1*1501-DQB1*0602--positive subjects. Hum Immunol. 2006. 67:749–755.
10. Park MH, Whang DH, Kang SJ. High resolution HLA-DQB1 typing by combination of PCR-RFLP and PCR-SSCP. Hum Immunol. 1999. 60:901–907.
Article
11. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders, 2nd edition. Sleep Med Rev. 2007. 11:377–388.
Article
12. Lee KW, Oh DH, Lee C, Yang SY. Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population. Tissue Antigens. 2005. 65:437–447.
Article
13. Lee KW, Jung YA, Oh DH. Diversity of HLA-DQA1 gene in the Korean population. Tissue Antigens. 2007. 69:Suppl 1. 82–84.
Article
14. Voorter CE, van den Berg-Loonen EM. Sequence-based typing of the complete coding sequence of DQA1 and phenotype frequencies in the Dutch Caucasian population. Hum Immunol. 2006. 67:756–763.
Article
15. Song EY, Park MH, Kang SJ, Park HJ, Kim BC, Tokunaga K, et al. HLA class II allele and haplotype frequencies in Koreans based on 107 families. Tissue Antigens. 2002. 59:475–486.
Article
16. Voorter CE, Kik MC, van den Berg-Loonen EM. High-resolution HLA typing for the DQB1 gene by sequence-based typing. Tissue Antigens. 1998. 51:80–87.
Article
17. Olerup O, Aldener A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens. 1993. 41:119–134.
Article
18. Bunce M, Taylor CJ, Welsh KI. Rapid HLA-DQB typing by eight polymerase chain reaction amplifications with sequence-specific primers (PCR-SSP). Hum Immunol. 1993. 37:201–206.
Article
19. Honda Y, Matsuki K. Thorpy M, editor. Genetic aspects of narcolepsy. Handbook of sleep disorders. 1990. New York: Marcel Dekker;217–234.
20. Dauvilliers Y, Bazin M, Ondzé B, Bera O, Besset A, Billiard M. Severity of narcolepsy among French of different ethnic origins (south of France and Martinique). Sleep. 2002. 25:50–55.
Article
21. Neely S, Rosenberg R, Spire JP, Antel J, Arnason BG. HLA antigens in narcolepsy. Neurology. 1987. 37:1858–1860.
Article
22. Watson NF, Ton TG, Koepsell TD, Gersuk VH, Longstreth WT Jr. Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status? Sleep. 2010. 33:29–35.
23. Bassetti C, Aldrich MS. Narcolepsy. Neurol Clin. 1996. 14:545–571.
Article
24. Hong SC, Lin L, Jeong JH, Shin YK, Han JH, Lee JH, et al. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep. 2006. 29:1429–1438.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr